Long-Fei Pan

Dr. Long-Fei Pan

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2021 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
JLJie Liu
Jie Liu
ZNZequn Niu
Zequn Niu
RZRui Zhang
Rui Zhang
ZPZhuo Peng
Zhuo Peng
LWLiming Wang
Liming Wang
LPLong-Fei Pan
Long-Fei Pan
Acute pancreatitis (AP) is a serious condition carrying a mortality of 25–40%. Extracellular vesicles (EVs) have reported to exert potential functions in cell‐to‐cell communication in diseases such as pancreatitis. Thus, we aimed at investigating the mechanisms by which EV‐encapsulated metastasis‐associated lung adenocarcinoma transcript‐1 (MALAT1) might mediate the M1 polarization of macrophages in AP. Expression patterns of MALAT1, microRNA‐181a‐5p (miR‐181a‐5p) and high‐mobility group box 1 protein (HMGB1) in serum of AP patients were determined. EVs were isolated from serum and pancreatic cells. The binding affinity among miR‐181a‐5p, MALAT1 and HMGB1 was identified. AP cells were co‐cultured with EVs from caerulein‐treated MPC‐83 cells to determine the levels of M1/2 polarization markers and TLR4, NF‐κB and IKBa. Finally, AP mouse models were established to study the effects of EV‐encapsulated MALAT1 on the M1 polarization of macrophages in AP in vivo. MALAT1 was transferred into MPC‐83 cells via EVs, which promoted M1 polarization of macrophages in AP. MALAT1 competitively bound to miR‐181a‐5p, which targeted HMGB1. Moreover, MALAT1 activated the TLR4 signalling pathway by regulating HMGB1. EV‐encapsulated MALAT1 competitively bound to miR‐181a‐5p to upregulate the levels of IL‐6 and TNF‐α by regulating HMGB1 via activation of the TLR4 signalling pathway, thereby inducing M1 polarization of macrophages in AP. In vivo experimental results also confirmed that MALAT1 shuttled by EVs promoted M1 polarization of macrophages in AP via the miR‐181a‐5p/HMGB1/TLR4 axis. Overall, EV‐loaded MALAT1 facilitated M1 polarization of macrophages in AP via miR‐181a‐5p/HMGB1/TLR4, highlighting a potential target for treating AP.

1 May 2021 in Life Sciences
Verified
Journal Article
Closed access
SRSong Ren
Song Ren
LPLong-Fei Pan
Long-Fei Pan
LYLinqing Yang
Linqing Yang
ZNZequn Niu
Zequn Niu
LWLiming Wang
Liming Wang
MYMiao Yuan
Miao Yuan

9 June 2022 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
RZRui Zhang
Rui Zhang
ZNZequn Niu
Zequn Niu
JLJie Liu
Jie Liu
XDXiaoyan Dang
Xiaoyan Dang
HFHui Feng
Hui Feng
ZPZhuo Peng
Zhuo Peng
Myocardial injury is a frequently occurring complication of sepsis. This study aims to investigate the molecular mechanism of long noncoding RNA (lncRNA) small nucleolar RNA host gene 1 (SNHG1)‐mediated DNA methyltransferase 1/B‐cell lymphoma‐2 (DNMT1/Bcl‐2) axis in sepsis‐induced myocardial injury. Mice and HL‐1 cells were treated with lipopolysaccharide (LPS) to establish animal and cellular models simulating sepsis and inflammation. LncRNA SNHG1 was screened out as a differentially expressed lncRNA in sepsis samples through microarray profiling, and the upregulated expression of lncRNA SNHG1 was confirmed in myocardial tissues of LPS‐induced septic mice and HL‐1 cells. Further experiments suggested that silencing of lncRNA SNHG1 reduced the inflammation and apoptotic rate of LPS‐induced HL‐1 cells. LncRNA SNHG1 inhibited Bcl‐2 expression by recruiting DNMT1 to Bcl‐2 promoter region to cause methylation. Inhibition of Bcl‐2 promoter methylation reduced the inflammation and apoptotic rate of LPS‐induced HL‐1 cells. In vivo experiments substantiated that lncRNA SNHG1 silencing alleviated sepsis‐induced myocardial injury in mice. Taken together, lncRNA SNHG1 promotes LPS‐induced myocardial injury in septic mice by downregulating Bcl‐2 through DNMT1‐mediated Bcl‐2 methylation.

1 January 2020
Verified
Journal Article
Closed access
BZB Zhang
B Zhang
YZYuhao Zhang
Yuhao Zhang
RLRunsheng Li
Runsheng Li
LZLei Zhao
Lei Zhao
SQShucun Qin
Shucun Qin
YGY-X Gao
Y-X Gao

16 March 2021 in Inflammation
Verified
Journal Article
Closed access
PDF file
LPLong-Fei Pan
Long-Fei Pan
ZNZequn Niu
Zequn Niu
YGYanxia Gao
Yanxia Gao
LWLiming Wang
Liming Wang
ZLZhong Liu
Zhong Liu
HPHonghong Pei
Honghong Pei

14 December 2021 in Experimental and Therapeutic Medicine
Verified
Journal Article
Closed access
PDF file
YGYazhou Gao
Yazhou Gao
LWLiming Wang
Liming Wang
ZNZequn Niu
Zequn Niu
HFHui Feng
Hui Feng
JLJie Liu
Jie Liu
LPLong-Fei Pan
Long-Fei Pan
Acute pancreatitis (AP) is a common gastrointestinal disease that affects 1 million individuals worldwide. Inflammation and apoptosis are considered to be important pathogenic mechanisms of AP, and high mobility group box 1 (HMGB1) has been shown to play a particularly important role in the etiology of this disease. MicroRNAs (miRs) are emerging as critical regulators of gene expression and, as such, they represent a promising area of therapeutic target identification and development for a variety of diseases, including AP. Using the online database query (microRNA.org), the current study identified a site in the 3' untranslated region of HMGB1 mRNA that was a viable target for miR‑340‑5p. The present study aimed to investigate the association between miR‑340‑5p and HMGB1 expression in pancreatic acinar cells following lipopolysaccharide (LPS) treatment by performing luciferase, western blotting and reverse transcription‑quantitative PCR assays. The results suggest that miR‑340‑5p attenuates the induction of HMGB1 by LPS, thereby inhibiting inflammation and apoptosis via blunted activation of Toll‑like receptor 4 and enhanced AKT signaling. Thus, the therapeutic application of miR‑340‑5p may be a useful strategy in AP via upregulation of HMGB1 and subsequent promotion of inflammation and apoptosis.